PacBio Files 2024 10-K, Details Financials
Ticker: PACB · Form: 10-K · Filed: Mar 17, 2025 · CIK: 1299130
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
PACB 2024 10-K filed. Revenue breakdown & R&D costs detailed. Check for future growth signals.
AI Summary
Pacific Biosciences of California, Inc. (PACB) filed its 2024 10-K on March 17, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The filing details revenue from product sales and services, along with research and development activities. Key financial figures and operational highlights for 2024 are presented, alongside risk factors and forward-looking statements relevant to the company's future prospects in the laboratory analytical instruments sector.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of Pacific Biosciences' financial health and strategic direction for the fiscal year 2024, impacting investment decisions and market perception.
Risk Assessment
Risk Level: medium — The company operates in a highly competitive and rapidly evolving technological sector, facing risks related to innovation, market adoption, and regulatory changes.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K filing.)
- 1231 — Fiscal Year End (Indicates the end date of the reporting fiscal year.)
- 20250317 — Filing Date (Date the 10-K was officially submitted to the SEC.)
Key Players & Entities
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (company) — Filer
- 2024 (date) — Fiscal Year End
- March 17, 2025 (date) — Filing Date
- Menlo Park, CA (location) — Business Address
- 3826 (number) — Standard Industrial Classification
FAQ
What were the total revenues for Pacific Biosciences in 2024?
The filing indicates revenue figures for the fiscal year ending December 31, 2024, broken down into product and service segments, though specific total dollar amounts are not provided in this excerpt.
What is Pacific Biosciences' Standard Industrial Classification (SIC) code?
Pacific Biosciences of California, Inc. is classified under SIC code 3826, which corresponds to Laboratory Analytical Instruments.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted to the SEC on March 17, 2025.
What is the company's primary business address?
The company's business address is 1305 O'Brien Drive, Menlo Park, CA 94025.
What is the SEC file number for Pacific Biosciences?
The SEC file number for Pacific Biosciences of California, Inc. is 001-34899.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 17, 2025 regarding PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).